bioMérieux S.A.
BMXXY | OTC
$10.19
+$0.21 (+2.10%)
At close: Oct 15, 2026, 2:40 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.99B | 4.07B | 4.12B | 3.98B | 3.81B | 3.67B | 3.7B | 3.59B | 3.46B | 3.38B | 3.22B |
Cost of Revenue | 1.91B | 1.91B | 1.84B | 1.82B | 1.79B | 1.79B | 1.77B | 1.66B | 1.51B | 1.43B | 1.38B |
Gross Profit | 2.08B | 2.16B | 2.28B | 2.16B | 2.02B | 1.89B | 1.93B | 1.93B | 1.95B | 1.95B | 1.84B |
Operating Income | 478.3M | 388.3M | 508.9M | 567.8M | 487.2M | 406.1M | 452.3M | 530.8M | 659.5M | 739.6M | 672.1M |
Interest Income | 7.6M | 14.3M | 19.8M | 14.4M | 2.8M | 1.1M | 1.2M | 1.2M | 1.4M | 1.7M | 1.7M |
Pretax Income | 607M | 525.6M | 493.8M | 549.9M | 487.7M | 412.7M | 466.5M | 550.2M | 680.1M | 748.3M | 633.9M |
Net Income | 462.4M | 397.3M | 377.9M | 432.2M | 411.3M | 357.6M | 385.9M | 452.3M | 552M | 601.1M | 508.6M |
Selling & General & Admin | 1.09B | 1.11B | 1.13B | 1.1B | 1.05B | 1.02B | 1.02B | 954.7M | 879M | 818.3M | 786.7M |
Research & Development | 528.7M | 685.3M | 664.7M | 491.5M | 474.4M | 460.1M | 465.8M | 446.6M | 414.8M | 389M | 376.7M |
Other Expenses | -16.9M | -25.1M | -25.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.6B | 1.77B | 1.77B | 1.59B | 1.53B | 1.48B | 1.48B | 1.4B | 1.29B | 1.21B | 1.16B |
Interest Expense | 8.3M | 15.8M | 20.3M | 16M | 5.4M | 4.4M | 2.2M | 4.9M | 8.8M | 9.1M | 20.9M |
Selling & Marketing Expenses | 383.4M | 791.2M | 802.5M | 783.8M | 758.6M | 725.5M | 739.3M | 701.5M | 625.4M | 573.5M | 573.3M |
Cost & Expenses | 3.51B | 3.68B | 56.3M | -144.5M | 3.32B | 3.27B | 3.25B | 3.06B | 2.8B | 2.64B | 2.54B |
Income Tax Expense | 145M | 128.8M | 123M | 124.8M | 88.7M | 89.9M | 113.5M | 109.7M | 131.9M | 149.4M | 126.1M |
Shares Outstanding (Basic) | 117.76M | 117.77M | 118.91M | 117.92M | 117.93M | 118.15M | 117.96M | 117.95M | 118.37M | 118.27M | 118.2M |
Shares Outstanding (Diluted) | 118.38M | 118.98M | 118.91M | 118.94M | 118.59M | 118.96M | 118.61M | 118.51M | 118.37M | 119.07M | 118.69M |
EPS (Basic) | 3.93 | 3.36 | 3.19 | 3.67 | 3.49 | 3.03 | 3.27 | 3.83 | 4.67 | 5.08 | 4.30 |
EPS (Diluted) | 3.90 | 3.34 | 3.17 | 3.64 | 3.47 | 3.01 | 3.25 | 3.82 | 4.65 | 5.05 | 4.28 |
EBITDA | 917.1M | 951.6M | 958.4M | 891.5M | 831.8M | 806.1M | 816.6M | 841.7M | 956.6M | 1.01B | 888M |
EBIT | 478.3M | 533.3M | 647.6M | 566M | 493.2M | 417.1M | 468.7M | 555.1M | 688.9M | 757.4M | 654.8M |
Depreciation & Amortization | 438.8M | 418.3M | 310.8M | 325.5M | 338.6M | 389M | 347.9M | 286.6M | 267.7M | 247.9M | 233.2M |
Add to Watchlist
Select watchlists to add or remove BMXXY